http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1270097-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0821 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10 |
| filingDate | 1985-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1990-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4b5c1a5348bf9de15c46a6ae6e6133d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8902e71e2352b5089469f47c346f9873 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3856388c866a44c931b363ca2797257b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b901e851b7f4441b14759112e6a5df24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb7a62a44255031afd7b551d92f78bb1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12c3656fa92bee58ac11f1e975e6f4f6 |
| publicationDate | 1990-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1270097-A |
| titleOfInvention | Substituted azetidinone compounds |
| abstract | ABSTRACT OF THE DISCLOSURE Substituted Azetidinone Compounds The present invention relates to substituted azetidinone compounds, their preparation, and medicaments containing them. More particularly, the present invention relates to compounds shown by general formula (I): (I) wherein one of R1 and R2 represents a substituted lower alkyl group, an azido group, an amino group, a lower acylamino group, a mercapto group or a lower alkylthio group and the other represents a hydrogen group, or, both represent hydrogen atoms or lower alkyl groups; R3 represents a hydrogen atom or a group shown by formula: (wherein X represents or (wherein R5 represents a hydrogen atom or a lower alkyl group) and Y represents a hydroxy group, a lower alkoxy group, an amino group, a mono- or di-lower alkulamino group); R4 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group or a group shown by formula: -CH2CO-A (wherein A represents an amino group or a group shown by formula: (wherein X and Y are as defined above), ABSTRACT OF THE DISCLOSURE (Cont'd) provided that when R1 and R2 are both hydrogen atoms, at least R4 represents a group other than a hydrogen atom and provided that either R3 or R4 represents a group other than a hydrogen atom, salts thereof, processes for producing them and medicaments containing these compounds. For example, the compounds of the present invention can be useful for improving disturbance of consciousness in schizophrenia, nervous depression the sequels to cerebro-vascular disorders, head injury, senile dementia, epilepsy etc., or improving hypobulia, depressive syndrome, memory loss, etc. |
| priorityDate | 1984-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 139.